PTC Therapeutics
PTCT
PTCT
125 hedge funds and large institutions have $636M invested in PTC Therapeutics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $715M → $636M (-$79.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
81% less call options, than puts
Call options by funds: $9.17M | Put options by funds: $48M
Holders
125
Holding in Top 10
4
Calls
$9.17M
Puts
$48M
Top Buyers
| 1 | +$49.2M | |
| 2 | +$16.2M | |
| 3 | +$10.6M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$10.6M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$10.4M |
Top Sellers
| 1 | -$79M | |
| 2 | -$12.3M | |
| 3 | -$9.42M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.62M |